News

By Dennis Thompson HealthDay ReporterWEDNESDAY, Oct. 16, 2024 (HealthDay News) — Public concerns about contracting RSV (respiratory syncytial virus) have significantly declined during the past year, a new survey shows.About 1 in 4 people (26%) are now worried that they or a family member will get RSV during the next …

Findings seen even for exposure below the U.S. Environmental Protection Agency guidelines

Prescriptions for GLP-1 RAs less common among White teens versus Black, Hispanic teens

Increased risk for myocarditis, pericarditis seen one to two weeks after COVID-19 mRNA vaccination

Approval is for endocrine-resistant, PIK3CA-mutated, HR-positive, HER2-negative disease

1,188,277 deaths could potentially be prevented over 12 months with optimal implementation of quadruple guideline-directed medical therapy

18.3 percent fewer deaths would have occurred had the rate of excess mortality seen in Whites been the same in total population

Longer progression-free survival seen with nivolumab + doxorubicin, vinblastine, and dacarbazine (AVD) versus brentuximab vedotin + AVD

Sensitivity higher, but some loss seen in specificity, when compared with Risk of Malignancy 1 index at threshold of 250

Higher ultraprocessed food intake tied to higher intakes of free sugar and sodium